The risks and benefits of sun exposure – Holick Oct 2016

Dermato-Endocrinology, 8:1, e1248325, DOI: 10.1080/19381980.2016.1248325
David G. Hoela, Marianne Berwickb, Frank R. de Gruijlc, and Michael F. Holick d
department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA; department of Internal Medicine and University of New Mexico Cancer Center, Division of Epidemiology and Biostatistics, University of New Mexico, Albuquerque, NM, USA; department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands; dSection of Endocrinology, Diabetes and Nutrition, Department of Medicine, Boston University Medical Center, Boston, MA, USA


I agree: Sun is better than UV, which is better than Vitamin D
But, if you cannot get the Sun or UVB due to time/seasn/cost, then take Vitamin D
Personally i hedge my bets and get all three

See also VitaminDWiki

 Download the PDF from VitaminDWiki

Public health authorities in the United States are recommending that men, women and children reduce their exposure to sunlight, based on concerns that this exposure will promote skin cancer. On the other hand, data show that increasing numbers of Americans suffer from vitamin D deficiencies and serious health problems caused by insufficient sun exposure. The body of science concerning the benefits of moderate sun exposure is growing rapidly, and is causing a different perception of sun/UV as it relates to human health. Melanoma and its relationship to sun exposure and sunburn is not adequately addressed in most of the scientific literature. Reports of favorable health outcomes related to adequate serum 25(OH)D concentration or vitamin D supplementation have been inappropriately merged, so that benefits of sun exposure other than production of vitamin D are not adequately described. This review of recent studies and their analyses consider the risks and benefits of sun exposure which indicate that insufficient sun exposure is an emerging public health problem. This review considers the studies that have shown a wide range health benefits from sun/UV exposure. These benefits include among others various types of cancer, cardiovascular disease, Alzheimer disease/dementia, myopia and macular degeneration, diabetes and multiple sclerosis. The message of sun avoidance must be changed to acceptance of nonburning sun exposure sufficient to achieve serum 25(OH)D concentration of 30 ng/mL or higher in the sunny season and the general benefits of UV exposure beyond those of vitamin D.


Public health authorities in the United States are currently advising that human sun exposure be reduced.1 At the same time, NHANES data show that 32% of Americans suffer from vitamin D insufficiency
In this paper we review the current state of the science of the risks and benefits of sun exposure and suggest that public health advice be changed to recommend that all men, women and children accumulate sufficient non-burning sun exposure to maintain their serum 25 hydroxyvitaminD [25(OH)D] levels at 30ng/mL or more year-round.

The first scientifically-established health benefit of sun exposure was the discovery in 1919 that sunlight cured rickets.4-5 This was followed in 1924 up by the discovery that an inactive lipid in the diet and skin could be converted by UV light into an antirachitic substance.6 The identification of vitamin D occurred in 1931.7 The association between sun exposure and reduced cancer mortality in North America was identified in the 1960s. In the 1980s, it was hypothesized that vitamin D was the protective factor. For most of the intervening years, instead of pursuing further benefits of sun exposure, scientific inquiry focused on the health risks of sun exposure, especially melanoma and other types of skin cancer.8 Chemical sunscreens were developed in 1928.9 Avoidance of intentional sun exposure and use of chemical sunscreens persisted as the standard advice of physicians and public health authorities for reducing the risk of melanoma and other forms of skin cancer.1'8 The risks of inadequate sun exposure have been largely ignored. Recently, however, scientific inquiry has increasingly turned to the benefits of moderate sun exposure and the public health risks of inadequate sun exposure.10

Risks of sun exposure Melanoma

The mechanism of melanoma is unknown, but is believed to be linked to genetic factors.11 The principal identified non-genetic risk factor is ultraviolet radiation (UVR) exposure, and the relationship between melanoma and UVR is 2-sided: non-burning sun exposure is associated with a reduced risk of melanoma, while sunburns are associated with a doubling of the risk of melanoma.12 It has long been observed that outdoor workers have a lower incidence of melanoma than indoor workers.13-19 A 1997 meta-analysis found an OR of 0.86 (95% CI: 0.77-0.96) for occupational sun exposure.18
Biologically, UVB is known to induce DNA damage through the creation of pyrimidine dimers while UVA does so at orders of magnitude less efficiently.20 Oxidative damage through the creation of free radicals (singlet oxygen and hydrogen peroxide) occurs at all UVR frequencies.20 However, the human body has many defenses against such damage including DNA repair mechanisms, cell cycle and growth inhibitions, reduced proliferation, enhanced sensitivity to apoptosis, enhancement of cellular differentiation and antiinflammatory effects; many of which are related to vitamin D produced by exposure to UVB.21-25
With respect to sunburns, melanocytes are not replicating cells, so once DNA damage has occurred, it is necessary for cellular replication to take place for the possibility of unrepaired or mis-repaired melanocytes to develop into malignant melanoma.20 Sunburns correspond with rare occasions of cell divisions and ensuing vulnerability to mutations in otherwise indolent melanocytes.20 With respect to chronic non-burning sun exposure, it is thought that protection against sunburn and development of melanoma derives from photo-adaptation (increased melanisation and epidermal thickening) or from the induction of higher levels of vitamin D, or possibly both.12'25-28 Vitamin D produced by UVB exposure is converted to the active form of vitamin D by its sequential metabolism in the liver to form the major circulating form of vitamin D, 25-hydroxyvitamin D [25(OH)D] which is then converted in the kidneys to 1,25-dihydroxyvitamin D [1,25(OH)2D]. Evidence suggests that vitamin D that is produced in the skin can also be converted in the skin to its active form 1,25(OH)2D25, thereby enhancing DNA repair29 and lowering cancer risk.
The incidence of melanoma in the United States has increased dramatically from 1 per 100,000 people per year in 1935 to 23 per 100,000 per year in 2012. Various explanations for this phenomenon have been suggested, including diagnostic drift,30 depletion of the ozone layer,31 the widespread use of artificial UVR devices,32 and the proliferation of large windows in office buildings.15 None of these explanations is particularly satisfactory for the reason that none explains the steady increase in melanoma incidence since 1935. While sunburns have been associated with a doubling of melanoma risk,12 chronic non-burning sun exposure and outdoor occupations have been associated with reduced risk of melanoma.12-19 Indoor occupations such as professional, managerial, clerical, sales and service workers grew from 25% to 75% of total employment between 1910 and 2000.33 25% of Americans lived on farms in 1930 whereas only 2% do so today.34 Indoor attractions such as air conditioning, television, computers and the internet probably have led to Americans spending more of their leisure time indoors, the prevalence of sunburns is high and has been increasing15, and serum 25(OH)D levels of the American public, a likely marker for sun exposure, are low and have been declining.c A more plausible explanation for the rise in melanoma incidence since 1935 may be the continually-increasing insufficient non-burning sun exposure and related increasing vitamin D deficiency/insufficiency, and the increasing sunburn prevalence experienced by the American public over the same time period d.

  • b According to the Centers for Disease Control and Prevention, the prevalence of sunburns increased from 32% of all adults in 1999 to 34% in 200435 and up to 50% in 2012. 36 Among adolescents aged 12-18 in 1999,83% reported at least one sunburn in the previous summer and 36% reported three or more sunburns in the previous summer.37
  • cData on temporal trends in vitamin D levels are contained in study by Ginde et al. 2009 38 who reported that NHANES data on serum 25(OH)D levels show that the prevalence of 25(OH)D of less than 10 ng/mL increased from 2% in 1988-1994 to 6% in 2001-2004 while over the same time period the prevalence of 25(OH)D of less than 20 ng/mL increased from 22% to 36%, and for 25(OH)D of less than 30 ng/mL increased from 55% to 77%.
  • dSuch an explanation is not new. White et al. 198839 (published as Garland et al. 199040) proposed that low levels of vitamin D (either locally available in skin or circulating in plasma) allow melanomas which were previously initiated by sunlight exposure to develop into clinically apparent disease in continually sunlight deprived individuals.

This proposal was apparently ignored as precautions against melanoma focused on sun avoidance and liberal use of chemical sunscreens, with inadequate attention paid to the role of sunburns in melanomagenesis and to the role of vitamin D in inhibiting cancer. The first cancer cell line shown in 1980 to be inhibited in growth by 1,25(OH)2D was in fact a melanoma cell line. In 1989 Gallagher et al.41 suggested that part of the increased incidence in melanoma could be attributed to the decline in outdoor workers.
Furthermore, epidemiological studies do not indicate any difference in melanoma risk based on the age at which UVR exposure occurs.12'17'18 Sunburns appear to be equally risky at any age.17 The public health messages of the past 50 y to avoid sun exposure and to use chemical sunscreens may have contributed to the rise in melanoma incidence.
We can find no consistent evidence that use of chemical sunscreens reduces the risk of melanoma. Green et al. 2011,42 found in a prospective study that there may be an association between sunscreen use and reduced risk of melanoma. However, since the participants were told they were participants in a skin cancer prevention trial and were questioned periodically during the trial on their use of sunscreen, the likelihood that they were significantly more diligent in applying sunscreen in accordance with manufacturers’ instructions than ordinary users of sunscreen cannot be discounted.e In addition, this study took place in a tropical environment, differing significantly from the environments of North America and Europe. Use of a placebo sunscreen was barred by ethical concerns.
Sunscreens do, however, reduce acclimatization to UVR and vitamin D production in the skin.46 Since public health authorities recommend liberal use of sunscreens for good health, the labeling of sunscreens should contain a statement about the possibility of vitamin D deficiency that may result from excessive use of sunscreens. Labeling should also state that sunscreens have not been shown to be effective in reducing the risk of melanoma. Sunscreens have been shown in one study to be effective in reducing the risk of squamous cell, but not basal cell, skin cancer.47

Nonmelanoma skin cancer (NMSC)
There are no official registries for basal cell carcinoma (BCC) or squamous cell carcinoma (SCC), and estimates of the prevalence of these carcinomas vary widely. One group of investigators examined Medicare fee-for-service data, extrapolated to the entire United States population, and estimated that 2,152,500 persons were treated for 3,507,693 NMSCs in 2006.48
e Sunscreens are intended to prevent sunburn when used in thickness and frequency recommended by manufacturers or used in setting SPFs. However, studies have shown that the incidence of sunburn is higher or the same in people who almost always use sunscreens compared with those who rarely use sunscreens.43-45

Several of the same investigators estimated that 3,315,554 persons were treated for 5,434,193 NMSCs in 2012 and revised the 2006 estimates to 2,463,567 persons and 4,013,890 NMSCs.49 These latter estimates indicated a 14% increase in Medicare NMSCs over the 6-year period 2006-2012 and a 54% increase in non-Medicare NMSCs over the 6-year period. It is not clear in this analysis that all treatments for NMSCs were in fact treatments for malignancies rather than for non-cancerous lesions, and these investigators found the ratio of BCC to SCC to be 1 to 1 instead of the expected 4 to 1. Another recent study50 which histologically confirmed all cases but studied only BCCs, calculated based on an analysis of a Kaiser Permanente BCC registry that approximately 2 million BCCs are treated annually in the United States in an undisclosed number of persons. Assuming a 4 to 1 ratio of BCC to SCC, this would indicate that 2.5 million NMSCs are treated annually. This study found that the incidence of BCC increased 17% during the 15-year period from 1998 to 2012.
As with melanoma, sunburns are associated with increased risk of SCC and BCC.16,17,51 Cumulative sun exposure, which is associated with decreased risk of melanoma, is apparently associated with increased risk of SCC and BCC, although the relationship between cumulative sun exposure and NMSC is not entirely clear. Armstrong and Kricker 2001 17 found that only SCC, not BCC, is related to total sun exposure, and Rosso et al. 1998 52 found no association between cumulative lifetime sun exposure and BCC. Kennedy et al. 200316 found a positive association between increasing lifetime sun exposure and the development of SCC and BCC but statistical significance was not always reached after age adjustment. English et al. 199853 found that total time spent outdoors was only weakly associated with SCC. Gallagher et al. 1995a,b 5455 found no association between cumulative lifetime sun exposure and risk of SCC or BCC, but Gallagher et al. 1995b55 found that occupational sun exposure in the 10 y prior to diagnosis was associated with increased risk of SCC. Many studies have found increased risk of SCC and to a lesser extent BCC from occupational sun exposure.17'51'56'57 Alam et al. 200158 found that the risk of SCC, but not BCC, is directly related to cumulative total dose of ionizing radiation from x-rays, that SCC may develop on sun- exposed areas in people with certain genodermatoses, such as oculocutaneous albinism, that chemical agents such as soot, arsenic and polycyclic hydrocarbons have historically been a major cause of SCC, and that human papillomavirus infection has been associated with SCC. The US. Preventive Services Task Force, in its May 2012 Final Recommendation Statement on skin cancer counseling,59'60 stated that studies that measured long-term or total sun exposure had found no association between cumulative sun exposure and either SCC or BCC.

Benefits of sun exposure; Risks of inadequate sun exposure

Scientific inquiry into the benefits of sun exposure languished for many decades following the observation in the 1920s that farmers in Europe developed nonmelanoma skin cancer on their most sun-exposed areas - their ears, face, nose and backs of their hands.61 Research on the benefits of sun exposure has accelerated in the past 15 y and particularly in the past 5 y.62

Vitamin D

Biological plausibility
Vitamin D is a hormone and most cells and organs in the human body have a vitamin D receptor, which explains the wide variety of diseases and disorders that have been linked to vitamin D insufficiency in epidemiological studies.63 The production of vitamin D by UV B radiation, the availability of vitamin D in food and supplements, and the biological plausibility of vitamin D as a mediator for a large variety of favorable health outcomes are well described in the literature.22-25,63-65
Recommended vitamin D status
There is considerable controversy within the scientific community regarding optimum 25(OH)D levels for human health. In 2010, the Institute of Medicine defined vitamin D deficiency as 25(OH)D of less than 12 ng/mL and vitamin D insufficiency as 25(OH)D of less than 20 ng/mL.2 In 2011, The Endocrine Society defined vitamin D deficiency as 25(OH)D below 20 ng/mL and vitamin D insufficiency as 25(OH)D of 21-29 ng/mL.66 Others have suggested even higher levels.22,67-69 A letter signed by many respected vitamin D scientists and physicians recommends 40-60 ng/mL70 which is in line with what the Endocrine Society recommended as the preferred range for health - i.e, a 25(OH)D of 40-60 ng/mL.66 Most reference laboratories have raised the lower boundary of the normal range to 30 ng/mL.68

Prevalence of vitamin D deficiency/insufficiency
Ginde et al. 20 0 9 38 reported that NHANES data on serum 25(OH)D levels show that the prevalence of 25 (OH)D of less than 10 ng/mL increased from 2% of the US population in NHANES III (1988-1994) to 6% in NHANES 2001-2004, and that over the same period the prevalence of 25(OH)D of less than 20 ng/ mL increased from 22% of the US population to 36%.f The IOM report did not offer a solution to this problem since that was not its purpose; the IOM was charged with determining the DRI of vitamin D supplements and found that there was insufficient scientific evidence on the benefits of vitamin D supplementation to support raising the DRI of vitamin D supplements to more than 600 International Units (IUs) per day.g Using the Endocrine Society’s definition of vitamin D sufficiency of 30 ng/mL, the level of vitamin D insufficiency increased from 55% of the US population in NHANES III to 77% in NHANES 2001-2004,38 which indicates that the vast majority of Americans have an insufficient vitamin D status.

Mediators other than vitamin D
Several studies, discussed below, have found that mediators other than vitamin D are or may be involved in the beneficial effects of adequate sun exposure.

Benefits of vitamin D/sun exposure; Risks of vitamin D insufficiency/inadequate sun exposure
We next examined the health benefits associated with increasing levels of sun exposure and/or circulating serum 25(OH)D and the health risks associated with inadequate sun exposure and/or inadequate serum 25 (OH)D, with particular emphasis on studies published since the 2010 IOM report.

  • f The differences between NHANES III and NHANES 2001-2004 may be attenuated by approximately 4 ng/mL after adjustment for improvements in the serum 25(OH)D assay performance from NHANES III to NHANES 20012004.71
  • g The Endocrine Society's 2012 review of the nonskeletal effects of vitamin D also found there was insufficient evidence to support a role of vitamin D supplementation in correcting vitamin D insufficiency.66

All-cause mortality
Chowdhury et al. 2014 72 performed a meta-analysis of data from 73 cohort studies with 849,000 participants and 22 randomized controlled trials with 31,000 participants. This study found an inverse association of circulating 25(OH)D with risks of death due to cardiovascular diseases, cancer and other causes (RR 1.35, 95% CI 1.22-1.49 for all cause mortality, comparing the bottom third versus top 2-thirds of baseline circulating 25(OH)D distribution), but found that, with respect to possible benefits of vitamin D supplementation, further investigation is required before any widespread supplementation occurs. The prevalence of vitamin D insufficiency (defined as 25(OH)D less than 30 ng/mL) was found to be 69.5% for the United States and 86.4% for Europe. The authors further estimate that 9.4% of all deaths in Europe and 12.8% in the United States could be attributable to vitamin D insufficiency. Other meta analyses include Garland et al. 2014 73 who pooled the data from 32 studies (30 cohort studies and 2 nested case-control studies) that examined age-adjusted all-cause mortality and serum 25(OH)D levels and found that the overall age- adjusted hazard ratio for all-cause mortality comparing the lowest (0-9 ng/mL) group to the highest (greater than 50 ng/mL) was 1.9 (95% CI 1.6-2.2), indicating that individuals in the lowest group had nearly twice the age-adjusted death rate as those in the highest quantile. Schottker et al. 2014 74 conducted a meta-analysis of 8 cohort studies with 26,000 participants and found a 1.6-fold higher all-cause mortality in the bottom quintile (25(OH )D approximately < 12 ng/mL) compared with the top quintile (25(OH) D approximately > 24 ng/mL) (RR 1.57, 95% CI 1.36-1.81).
Lindqvist et al. 2014 75 assessed the avoidance of sun exposure as a risk factor for all-cause mortality for 29,518 Swedish women in a prospective 20-year follow-up of the Melanoma In Southern Sweden cohort and found that the population attributable risk for allcause mortality for those habitually avoiding sun exposure was 3%. As compared to the highest sun exposure group, the all-cause mortality rate was doubled (RR 2.0, 95% CI 1.6-2.5) among avoiders of sun exposure and increased by 40% (RR 1.4, 95% CI 1.1-1.7) in those with moderate exposure. The authors noted that Sweden has national guidelines providing restrictive advice on sun exposure habits in order to lower the risk of skin cancer, and stated that these guidelines may be harmful in terms of overall health of the population. Lindqvist et al. 2016 76 found that women with active sun exposure habits were mainly at lower risk of cardiovascular disease mortality and other non-cancer mortality, and noted that avoidance of sun exposure is a risk factor for death of a similar magnitude as smoking. “Our finding that avoidance of sun exposure was a risk factor for all-cause death of the same magnitude as smoking is novel.”
Afzal et al. 2014 77 conducted a Mendelian randomization analysis showing that genetically low 25(OH)D levels were associated with increased all-cause mortality, but not with cardiovascular mortality. These results confirm that the measured low 25(OH)D levels in the general population associated with increased mortality as indicated in the above meta-analyses are related to vitamin D rather than simply a consequence of poor health or sequestration of vitamin D in adipose tissue, but indicate that some mediator other than vitamin D may be involved in cardiovascular mortality. Afzal et al. 2014 77 was the first study with sufficient sample size to investigate the association of genetically low 25(OH)D levels with increased mortality.

Colorectal cancer

Rebel et al. 2014 78 showed for the first time the causality of the relationship between moderate UVR exposure and primary intestinal tumors in mice. The UVR-induced reduction in intestinal cancer in mice could at least in part be attributed to vitamin D. However, the investigators also found a reduced progression to malignancy as a result of UVR exposure which appeared not to be attributable to vitamin D. Three groups of hairless mice were compared: one on a low- vitamin D diet without vitamin D supplementation or UVR exposure, one on a low-vitamin D diet with vitamin D supplementation but without UVR exposure, and one on a low-vitamin D diet without vitamin D supplementation but with moderate UVR exposure. This permitted the comparison of effects of dietary vitamin D supplementation and UVR exposure. The tumor load (area) was similarly and significantly reduced in both the vitamin D supplementation group and the UVR exposure group, but only the UVR exposure group had a lower percentage of malignant adenocarcinomas. Thus the study provided the first experimental evidence that physiologically relevant, moderate UVR exposure can reduce the load of primary intestinal tumors, which reduction can at least in part be explained by an increase in vitamin D status as a comparable reduction in tumor load was observed in the vitamin D supplementation group that had a similar increase in vitamin D status. However, a reduction in malignant progression and growth of adenocarcinomas could not be attributed to vitamin D as these effects were only observed with moderate UVR exposure and not with dietary vitamin D supplementation. Rebel et al. 2014 78 noted that prior studies had long shown that low exposure to solar UVR is significantly associated with increased risk of colon cancer, and that several recent studies showed that increased risk of colon cancer was significantly associated with prediagnostic low vitamin D status. The 2010 IOM report64 acknowledged that epidemiological studies examining associations between vitamin D status and colorectal cancer incidence generally supported an inverse association, but declined to base vitamin D DRI’s on colon cancer outcomes because of the paucity and conflicting findings of prospective randomized controlled trials involving vitamin D supplementation. Notably, the most recent, and only observational, study reviewed in the IOM report found no association of vitamin D supplementation with colon cancer risk, but found that patients in the highest quintile of prediagnostic circulating 25(OH)D concentration (more than 40 ng/mL) had a 42% reduced risk of colon cancer as compared to patients with the lowest quintile (less than 10 ng/mL).79

Breast cancer incidence and mortality

Mohr et al. 2014 80 conducted a meta-analysis of data from 5 studies on the relationship between serum 25 (OH)D levels at time of breast cancer diagnosis and breast cancer mortality which found that patients in the highest quintile of 25(OH)D (more than 32 ng/ mL) had approximately half the death rate from breast cancer as those in the lowest quintile (less than 14 ng/ mL) (HR 0.56; 95% CI: 0.4-0.7). The authors recommended that serum 25(OH)D levels in all breast cancer patients should be restored to the normal range, which the authors defined as 30-80 ng/mL.
Engel et al. 2010 81 found a 27% reduced risk of breast cancer incidence in women in the highest tertile of 25(OH)D (greater than 27ng/mL) as compared to the lowest tertile (less than 19.8 ng/mL) in a nested case-control study (OR 0.73; 95% CI: 0.55-0.96). The authors noted that all 6 previous case-control studies on the subject have reported a significant inverse association between serum 25(OH)D levels and breast cancer and that an inverse effect between sun exposure and breast cancer has previously been observed. John et al. 1999 82 found that women with higher solar UVB exposure in NHANES III had only about half the incidence of breast cancer as those with lower solar exposure (RR 0.50; 95% CI: 0.33-0.80) and Knight et al 2007 83 found that increasing sun exposure from ages 10 to 19 reduced breast cancer risk by 35% (OR 0.65, 95% CI 0.50-0.85 for the highest quartile of outdoor activities vs. the lowest).

Non-hodgkins lymphoma, colorectal, prostate and breast cancer, and multiple sclerosis

Van der Rhee et al. 2013 84 noted that the association between solar radiation and reduced cancer mortality in North America was identified more than 60 y ago 85 and that in 1980 it was hypothesized that vitamin D was the protective factor.40 The authors conducted a systematic review to verify if epidemiological evidence is in line with the hypothesis that the possible preventive effect of sunlight on cancer is more than just the effect of vitamin D. Vitamin D intake studies were excluded from the review and the authors stated that their review presented the sum of epidemiological knowledge on the influence of sun exposure and circulating 25(OH)D levels on the risk of colorectal cancer, prostate cancer, breast cancer and non-Hodgkin’s lymphoma (NHL). They concluded that:

  • 1) there is an inverse association between sun exposure and both colorectal cancer risk and colorectal cancer mortality;
  • 2) there is an inverse association between vitamin D status and both colorectal cancer risk and colorectal cancer mortality;
  • 3) there is a negative association between sun exposure and prostate cancer risk and prostate cancer mortality but not between vitamin D status and prostate cancer risk or mortality;
  • 4) there is an inverse correlation between sun exposure and breast cancer risk and breast cancer mortality, and possibly between 25(OH)D and breast cancer mortality, but studies on the association between 25(OH)D and breast cancer risk are inconclusive;
  • 5) there is a negative association between sun exposure and NHL risk and NHL mortality but not between vitamin D status and NHL risk or mortality;
  • 6) there is a negative association between sun exposure and lymphoma risk, but no association between lymphoma risk and vitamin D intake or 25(OH)D levels; and,
  • 7) for multiple sclerosis, both experimental and epidemiological studies show that the preventative role of sun exposure is independent of vitamin D production.

The authors concluded that for colorectal cancer and breast cancer the benefit of sun exposure is mediated by high vitamin D levels produced by sun exposure, whereas for prostate cancer, NHL and multiple sclerosis the benefit of sun exposure is independent of vitamin D.84

Bladder cancer

Zhao et al. 2016 86 found a 30% reduced risk of bladder cancer associated with 25(OH)D concentrations above 30 ng/mL compared to less than 15 ng/mL.

Cardiovascular disease (CVD)

Liu et al. 2014 87 found that hypertension is reduced by UVR-induced nitric oxide independent of vitamin D. They showed that stores of nitrogen oxides in the human skin are mobilized to the systemic circulation by exposure of the body to UVA radiation, causing arterial vasodilation and a resultant decrease in blood pressure independent of vitamin D, confirming the hypothesis of Feelisch et al. 20 1 0.88 These results correlate with the findings of Afzal et al. 2014 77 that genetically low 25(OH)D levels were associated with increased all-cause mortality but not with cardiovascular mortality, indicating that a mediator other than vitamin D may be involved in cardiovascular mortality, and with the results of Tunstall-Pedoe et al. 2015 89 challenging vitamin D’s alleged role in cardiovascular disease.

Metabolic syndrome (MetS) and type 2 diabetes

Vitezova et al. 2015 90 found that higher 25(OH)D levels were associated with lower prevalence of metabolic syndrome (OR 0.61, 95% CI 0.49-0.77 for more than 30 ng/mL versus less than 20 ng/mL) in the elderly in an analysis of data from 3240 people (median age 71.2 years) imbedded in the Rotterdam Study, a prospective population-based cohort study of middle- aged and elderly adults. Importantly, after adjustment for body mass index (BMI), higher 25(OH)D levels were still significantly associated with lower odds of MetS. Almost concurrent with Vitezova et al. 2015, Clemente-Postigo et al. 2015 91 showed that low 25 (OH)D levels are associated with type 2 diabetes independently of BMI. These findings are important in light of the 2010 IOM report’s discounting of the association studies linking low 25(OH)D levels to increased risk of type 2 diabetes on the ground that they may be confounded by obesity, which not only predispose individuals to type 2 diabetes but may also cause lower 25(OH)D levels as a result of sequestration of vitamin D in adipose tissue and possibly other mechanisms. Vitezova et al. 2015 noted that other recent studies had found an inverse association between vitamin D status and MetS in younger populations, but only one other study of older persons had found the association while another study of older persons had not. Neither Vitezova et al. 2015,125 nor Clemente-Postigo et al. 2015 91 cited Geldenhuys et al. 2014,92 which found that UVR exposure levels, not vitamin D supplements or 25(OH)D levels, reduced the risk of obesity and type 2 diabetes, indicating that 25(OH) levels may be to some extent a marker for UVR exposure in this regard.
Afzal et al. 2013 93 measured 25(OH)D levels in 9841 persons of whom 810 developed type 2 diabetes during 29 y of follow-up. The investigators observed an association of low 25(OH)D with increased risk of type 2 diabetes (HR 1.35, 95% CI 1.09-1.66 for lowest (less than 5 ng.mL) vs. highest (more than 20 ng/mL) quartile of 25(OH)D. This finding was substantiated by the authors’ meta-analysis of 14 studies representing 16 cohorts with a total of 72,204 participants and 4,877 type 2 diabetes events (HR 1.50, 95% CI 1.331.70 for the bottom vs. top quartile of 25(OH)D). A prior 2011 meta-analysis [134 Mitri 2011 94] had shown that individuals with 25(OH)D levels above 25 ng/mL had a 43% lower risk of developing type 2 diabetes (95% CI, 2457%-) compared with individuals with 25(OH)D levels below 14 ng/mL, and that vitamin D supplementation had no effect.

Alzheimer disease and cognitive decline

Littlejohns et al. 2014 95 [135] studied a group of 1,658 Americans age 65 and older who were able to walk unaided and who were free of dementia. The participants were followed for 6 y to investigate who went on to develop Alzheimer disease and other forms of dementia. The investigators found that participants with serum 25(OH)D levels below 10 ng/mL were more than twice as likely to develop Alzheimer disease than participants with serum 25(OH)D levels greater than 20 ng/mL (HR 2.22, 95% CI 1.02-4.83) and participants with serum 25(OH)D levels of 10 ng/mL to 20 ng/mL were 69% more likely to develop Alzheimer disease than participants with serum 25(OH)D levels greater than 20 ng/mL (HR 1.69, 95% CI 1.06-2.69). Similar results were obtained for all-cause dementia. According to the authors, this was the first large, prospective, population-based study incorporating a comprehensive adjudicated assessment of dementia and Alzheimer to examine their relationship with vitamin D concentrations. This study confirms other recent studies linking low vitamin D levels with cognitive decline.96-102
Keeney et al. 2013 96 manipulated vitamin D status in middle-age to old-age rats by dietary supplementation with low, moderate and high levels of vitamin D. The results suggested that dietary vitamin D deficiency contributes to significant nitrosative stress in the brain and may promote cognitive decline in middle-age and elderly humans.
Annweiler et al. 2013 97 was a systematic review and meta-analysis finding that 25(OH)D levels were lower in Alzheimer cases than in controls (summary random effect size 1.40, 95% CI 0.262.54), which means that the probability is about 140% that an individual without Alzheimer would have a higher 25(OH)D level than an individual with Alzheimer if both individuals were chosen at random from a population.

Multiple sclerosis (MS), type 1 diabetes, rheumatoid arthritis

Wang et al. 2014 103 found that UVR suppressed experimental autoimmune encephalomyelitis (EAE - an animal model of MS), independent of vitamin D production, confirming the conclusions of van der Rhee et al. 2013 84 and the findings of Becklund et al. 2010.104 The investigators showed that UVB irradiation did not suppress immune response in the periphery, but suppressed EAE by blocking selectively the infiltration and binding of inflammatory cells into the central nervous system. These findings support the long-held view that the incidence of MS is inversely related to UVR expo– ? ?
Baarnhielm et al. 2012 110 was an association study finding that persons with low UVR exposure had a significantly increased risk of MS compared with those who reported the highest exposure (OR 2.2, 95% CI 1.5-3.3), and that this association persisted after adjustment for vitamin D status. Wang et al. 2014 103 and Baarnhielm et al. 2012 110 confirmed the conclusions of van der Rhee et al. 2013 83 that sun exposure reduces the risk of MS through pathways independent of vitamin D.
Ponsonby et al. 2005 108 stated that genetic factors appear to be involved in MS, but the low concordance among identical twins for MS 111 and trends of increasing incidence of MS over time 112 suggest environmental factors are also important determinants, and that UVR exposure may be one factor that can attenuate MS through several mechanisms and that some the pathways are independent of vitamin D. Similar conclusions were made about 2 other autoimmune diseases, type 1 diabetes and rheumatoid arthritis. The authors concluded that it was critical to consider the benefits of sun exposure as well as the risks, and to provide information to the public on the minimum sun exposure required for beneficial health effects as well as the maximal sun exposure to avoid the adverse health effects associated with excessive sun exposure. Mokry et al. 2015 113 was a Mendelian randomization analysis showing that genetically low 25(OH)D levels were associated with increased risk of MS. Jalkanen et al. 2015 114 found a high level of vitamin D deficiency during pregnancy in MS patients.
Jacobsen et al. 2015 115 found that more sun exposure in the third gestational trimester was associated with lower risk of type 1 diabetes in male children. Sawah et al. 2016 116 found a high prevalence of vitamin D deficiency (25(OH)D levels less than 20 ng/ mL) in children and adolescents with type 1 diabetes. Kostoglou-Athanassiou et al. 2012 117 found a high prevalence vitamin D deficiency in patients with rheumatoid arthritis.


Gisondi et al. 2012 118 found that the prevalence of 25(OH)D of less than 20 ng/mL was 57.8% in patients with psoriasis vs. 29.7% in healthy controls, and that in a logistic regression analysis, vitamin D deficiency was associated with psoriasis independently of other factors (OR 2.50, 95% CI 1.18-4.89).
The investigators noted that topical vitamin D derivatives and UVB radiation are used in the treatment of psoriasis. Vitamin D status was found to be unrelated to levels of self-reported sun exposure, but the measure used for sun exposure, which was minutes per day of sun exposure from March to September, may not have been appropriate for vitamin D production since it apparently did not include the time of day or the area of skin exposed.

Liver disease

Gorman et al. 2015 119 in a review stated that a large number of studies in recent Years 92'120'121 have shown that exposure to UVR has the potential to curtail the development of non-alcoholic fatty liver disease (NAFLD) through vitamin D dependent and vitamin D independent mechanisms. The authors noted that most observational studies support an inverse association between serum 25(OH)D levels and NAFLD, but that vitamin D supplementation did not produce the same results. The authors further stated that circulating vitamin D levels may represent a proxy for bodily exposure to sunlight 122 explaining the observation that mediators induced by sun exposure other than vitamin D may play important roles in curtailing NAFLD.

Statin intolerance and muscle pain, weakness

Khayznikov et al. 20 1 567 found that statin intolerance because of myalgia, myositis, myopathy, or myonecrosis associated with serum 25(OH)D less than 23 ng/mL can be resolved with vitamin D supplementation raising serum 25(OH)D to 53 ng/ mL. Aleksic et al. 20 1 5 123 found that low vitamin D levels are a potentially significant and correctible risk factor for statin-related myopathy, especially in African-Americans.

Macular degeneration

Millen et al. 2015 124 observed a 6.7-fold increased risk of age-related macular degeneration (AMD) among women with serum 25(OH)D levels less than 12 ng/ mL who also had genetic risk for AMD, and noted that previous studies had found that decreased odds of AMD are associated with high compared to low concentrations of 25(OH)D.

Dental caries in infants

Schroth et al. 2014 125 found that low prenatal 25(OH) D concenratations were associated with increased risk of dental caries among offspring in the first year of life.

Reverse causation

Autier et al. 2014 126 suggested that low serum 25(OH) D levels may be the result rather than the cause of diseases associated with low serum 25(OH)D levels in observational studies (reverse causation). The authors offer little evidence to support such a hypothesis, and it is contraindicated by the prospective nature of many of the studies linking serum 25(OH)D levels with health outcomes, by Mendelian randomization studies77413 and by the body of knowledge concerning the bioactivity of vitamin D, particularly its cancer- inhibiting properties.


Geldenhuys et al. 2014 92 suggests that UVR exposure may be an effective means of suppressing the development of obesity and metabolic syndrome through mechanisms that are independent of vitamin D but dependent on other UVR-induced mediators such as nitric oxide. This study investigated whether UVR and/or vitamin D supplementation had an effect on the development of obesity and type 2 diabetes in mice fed a high-fat diet, and found that UVR significantly suppressed weight gain but vitamin D supplementation did not. These results indicate that low vitamin D status in obese persons may only be a marker for low UVR exposure or a result of sequestration of vitamin D in adipose tissue, and provide a new view of previous studies showing a consistent association between increasing body mass index and lower serum 25(OH)D levels.127


French et al. 2015 128 was a review stating that recent epidemiological evidence suggests that children who spend more time outdoors are less likely to be or to become myopic, irrespective of how much near work they do or whether their parents are myopic. The likely mechanism for this protective effect is visible light stimulating release of dopamine from the retina, which inhibits increased axial elongation, the structural basis of myopia.
The authors describe the effect of time outdoors on the risk of myopia as robust. The prevalence of myopia in the US in persons 12 to 54 y old increased 66% between 1971-1972 and 1999-2004, from 25.0% to 41.6%, according to the National Eye Institute of the National Institutes of Health.129'130 For African Americans, the increase was 157.7%.130 This high prevalence of myopia presents a major public health problem since, in addition to requiring corrective lenses, myopia poses substantially increased risk of retinal detachment, glaucoma, macular degeneration, amblyopia and cataracts.131,132

Other benefits of sun exposure

Lambert et al. 2002 133 suggested that the prevailing amount of sunlight affects brain serotonergic activity. Deficiencies in serotonin and brain serotonergic activity have been linked to sudden infant death syndrome,134 seasonal affective disorder,133 depression,135 schizophrenia,136 Alzheimer disease,137 and migraine headaches.138 Beta-endorphin, a neuoro- hormone that acts as an analgesic, has been known for many years to be released in the human body by exercise,139 producing a feeling of wellbeing similar to the feeling of wellbeing induced by sun exposure. A recent study showed that UVR exposure significantly raised circulating plasma b-endorphin levels in a UV-exposure mouse model, leading to suggestions that UVR exposure is addictive.140 Alternatively, the release of b-endorphins by sun exposure could be a natural reward mechanism encouraging sun exposure.
The benefits of serotonin and b-endorphin, as well as the effects of sun exposure on melatonin, photodegradation of folic acid, immunumodulation, photoadaptation, and circadian clocks, are reviewed in van der Rhee et al. 2016. 10

Vitamin D supplements vs. sun exposure

In light of the studies discussed in this review that found health outcomes related to sun exposure independent of vitamin D, health outcomes dependent on serum 25(OH)D levels but not vitamin D supplementation, and health outcomes dependent on mediators other than vitamin D, it is apparent that vitamin D supplements are not an effective substitute for adequate sun exposure.

Balancing the risks of moderate non-burning sun exposure against the risks of inadequate sun exposure

The only identified risk associated with the amount of non-burning sun exposure needed to achieve serum 25(OH)D levels of 30 ng/mL is some possible increased risk of nonmelanoma skin cancer. The amount of sun exposure required to produce this level of vitamin D varies among individuals and according to time of year, time of day and latitude. White people with Type II skinsh at 40 degrees latitude can obtain their annual requirements of vitamin D by spending about 15 minutes in the sun with face, arms and legs exposed (half that time if in a bathing suit) 2 to 3 times a week between 11 a.m. and 3 p.m. during the months of May through October.141 In comparison, nonmelanoma skin cancer is associated with many thousands or tens of thousands of cumulated hours of lifetime sun exposure.16,52,53
Moreover, inadequate acclimatization to UVR in daily life carries the risk of sunburn and corresponding increased risk of both nonmelanoma skin cancer and melanoma.
The risks of inadequate non-burning sun exposure include increased risks of all-cause mortality, colorectal cancer, breast cancer, non- Hodgkins lymphoma, prostate cancer, pancreatic cancer, hypertension, cardiovascular disease, metabolic syndrome, type 2 diabetes, obesity, Alzheimer disease, multiple sclerosis, type 1 diabetes, rheumatoid arthritis, psoriasis, non-alcoholic fatty liver disease, statin intolerance, macular degeneration and myopia.
People with darker skins require more time in the sun to produce their requirements of vitamin D but also have lower risks of nonmelanoma skin cancer, and people with Type I skins, who are unable to tan, require less time in the sun but have higher risks of nonmelanoma skin cancer. All persons should avoid sunburns, which are associated with substantial increased risk of melanoma and nonmelanoma skin cancer.
hThere are 6 categories of skin on the Fitzpatrick Scale: Type I Very Fair White - always burns, never tans;Type II Fair White - usually burns, tans minimally; Type III Cream White - sometimes mild burn, gradually tans; Type IV Brown - rarely burns, tans with ease; Type V Dark Brown - very rarely burns, tans very easily; Type VI Black - never burns, tans very easily.


Insufficient sun exposure has become a major public health problem, demanding an immediate change in the current sun-avoidance public health advice. The degree of change needed is small but critically important. The public must be advised to obtain enough sun exposure and vitamin D supplementation to maintain a serum 25(OH)D level of at least 30 ng/mL. The skin has a large capacity to produce vitamin D and a single whole body exposure to an amount of sunlight that is equal to 1 minimal erythemal dose is equivalent to ingesting approximately 15,000-20,000 IUs of vitamin D. Therefore to produce an equivalent of 4000 IUs of vitamin D a day would require that 50% of the body surface be exposed to 0.5 MEDs. To achieve a blood level of at least 30 ng/ML would require ingesting 2000 IUs of vitamin D daily which would be equivalent to 25% of the body surface exposed to 0.5 MEDs 2-3 times a week.24

Comment by VitaminDWiki:

2,000 IU gets the average to 30 ng. Need about 4,000 IU to get most people above 30 ng.
This would require 1/2 of body exposed to 1/2 med DAILY - not just 2-3 times a week

   Note - It is dfficult to get daily noon sun all year- especially in regions far from equator

The amount of sun exposure required to achieve an MED depends on skin pigmentation, latitude, time of day and time of year. Warnings on the dangers of sunburn at any age should be emphasized. Periodic testing of serum 25(OH)D levels is also reasonable especially at the end of the summer which is when the blood level of 25(OH)D is at its highest level.141


5(OH)D25-hydroxyvitamin D
BCCbasil cell carcinoma
CIconfidence interval
CVDcardiovascular disease
HRhazard ratio
IUinternational units
MSmultiple sclerosis
NMSCnon-melanoma skin cancer
ng/mLnanograms per milliliter
NHLnon-Hodgkins lymphoma
ORodds ratio
RRrelative risk
SCCsquamous cell carcinoma
UVR Ultraviolet Radiation (290-400 nm)
UVAUltraviolet-A (316-400 nm)
UVBUltraviolet-B (290-315 nm)

Disclosure of potential conflicts of interest: No potential conflicts of interest were disclosed.

ORCID: Michael F. Holick


  1. The Surgeon General’s Call to Action to Prevent Skin Cancer, U.S. Department of Health and Human Resources, Office of the Surgeon General, Washington, D.C; 2014.; Sun Exposure, Centers for Disease Control and Prevention travel/page/sun-exposure; Guidelines for School Programs to Prevent Skin Cancer, Centers for Disease Control and Prevention _ doing/guidelines.htm; How Can I Protect My Children from the Sun?, Centers for Disease Control and Prevention,; What Can I Do to Reduce My Risk of Skin Cancer?, Centers for Disease Control and Prevention cer/skin/basic_info/prevention.htm.
  2. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D, pages S-11 and 8-7. National Academies Press. 2010.
  3. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D Status: United States, 2001-2006. NCHS Data Brief, No. 59, March 2011.
  4. Huldshinsky K. Heilung von rachitis durch kunstlich hohen-sonne. Deut Med Wochenscher 1919; 45:712-3; Huldshinsky K. The ultra-violet light treatment of rickets. Alpine Press New Jersey, USA 1928, 3-19.
  5. Hess AF, Unger LL. The cure of infantile rickets by sunlight. JAMA 1921; 77:39-41.
  6. Steenbock H, Black A. Fat-soluble vitamins XXIII. The induction of growth-promoting and calcifying properties in fats and their unsaponifiable constituents by exposure to light. J Biol Chem 1925; 64:263-98.
  7. Askew FA, Bourdillon RB, Bruce HM, Jenkins RGC, Webster TA. The distillation of vitamin D. Proc R Soc 1931; B107:76-90.
  8. Albert MR, Ostheimer KG. The evolution of current medical and popular attitudes toward ultraviolet light exposure: part 3. J Am Acad Dermatol 2003; 49:1096106; PMID:14639391;
  9. Shaath NA. Evolution of modern sunscreen chemicals. In:Lowe NJ, Shaath NA, editors. Sunscreens: development, evaluation and regulatory aspects. New York: M. Dekker. 1990:3-35.
  10. van der Rhee H, de Vries E, Coomans C, van de Velde P, Coebergh JW. Sunlight: For better or for worse? A review of positive and negative effects of sun exposure. Cancer Res Front 2016: 2:156-83; 10.17980/2016.156
  11. Nelson AA, Tsao H. Melanoma and genetics. Clinics in Dermatol 2009; 27:46-52;
  12. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, Melchi CF. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41:45-60; PMID:15617990;
  13. Vuong K, McGeechan K, Armstrong BK, AMFS Investigators, GEM Investigators, Cust AE. Occupational sun exposure and risk of melanoma according to anatomical site. Int J Cancer 2014; 134:2735-41; PMID:24288300;
  14. Moan J, Porojnicu AC, DAhlback A, Setlow RB. Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. PNAS 2008; 105:668-73; PMID:18180454;
  15. Godar DE, Landry RJ, Lucas AD. Increased UVA exposures and decreased cutaneous Vitamin D3 levels may be responsible for the increasing incidence of melanoma. Med Hypoth 2009; 72:434-43; 10.1016/j.mehy.2008.09.056
  16. Kennedy C, Bajdik CD, Willemze R, de Gruijl FR, Bavinck JNB. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 2003; 120:1087-93; PMID:12787139;
  17. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol 2001; 63:818;
  18. Elwood JM, Jopson J. Melanoma and sun exposure: An overview of published studies. Int J Cancer 1997; 73:198-203; PMID:9335442; 3e3.0.CO;2-R
  19. Green AC, O’Rourke MGE. Cutaneous malignant melanoma in association with other skin cancers. JNCI 1985; 74:977-80; PMID:3858585
  20. van Schanke A, Jongsma MJ, Bisschop R, van Venrooij GMCAL, Rebel H, de Gruijl FR. Single UVB overexposure stimulates melanocyte proliferation in murine skin, in contrast to fractionated or UVA-1 exposure. J Invest Dermatol 2005; 124:241-7; PMID:15654980; http://dx.
  21. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D, Chapter 3. National Academies Press. 2010:91-92.
  22. Holick MF. Vitamin D Physiology, Molecular Biology, and Clinical Applications, Second Ed. Humana Press 2010.
  23. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Murad MH, Kovacs CS. The nonskeletal effects of vitamin D: An endocrine society scientific statement. Endocrine Reviews 2012; 33:456-92; PMID:22596255;
  24. Wacker M, Holick MF. Sunlight and vitamin D: A global perspective for health. Dermato-Endocrinol 2013; 5:51-108;
  25. Bikle DD. The Vitamin D Receptor: A Tumor Suppressor in Skin. Sunlight, Vitamin D and Skin Cancer, Chapter 16, Second Edition. Jorg Reichrath, editor. Landes Bioscience and Springer Science+Business Media. 2014:282-302
  26. Newton-Bishop JA, Chang Y, Elliott F, Chan M, Leake S, Karpavicius B, Haynes S, Fitzgibbon E, Kukalizch K, Randerson-Moor J, et al. Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate. Eur J Cancer 2011; 47:732-741; PMID:21084183; http://dx.doi. org/10.1016/j.ejca.2010.10.008
  27. Reichrath J, Reichrath S. The relevance of the vitamin D endocrine system (“VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectives. Der- mato-Endocrinology 2013; 5:38-50; PMID:24494041;
  28. Dixon KM, Norman AW, Sequeira VB, Mohan R, Rybchyn MS, Reeve VE, Halliday GM, Mason RS. 1a, 25(OH)2-vitamin D and a nongenomic vitamin D analogue inhibit ultraviolet radiation-induced skin carcinogenesis. Cancer Prev Res 2011; 4:1485-94; http://dx.doi. org/10.1158/1940-6207.CAPR-11-0165
  29. Gordon-Thomson C, Tongkao-on W, Song EJ, Carter SE, Dixon KM, Mason RS. Protection from ultraviolet damage and photocarcinogenesis by vitamin D compounds. Adv Exp Med Biol 2014; 810:303-28; PMID:25207373
  30. Levell JN, Beattie CC, Shuster S, Greenberg DC. Melanoma epidemic: a midsummer night’s dream? Br J Dermatol 2009; 161:630-4; PMID:19519827; http://dx.
  31. Schaart FM, Garbe C, Orfanos CE. Disappearance of the ozone layer and skin cancer; attempt at risk assessment. Hautarzt 1993; 44:63-8; PMID:8449695
  32. Lazovich D, Vogel RI, Berwick M, Weinstock MA, Anderson KE, Warshaw EM. Indoor tanning and risk of melanoma: a case-control study in a highly exposed populations. Cancer Epidemiol Biomarkers Prev 2010;19:1557-68;
  33. Ian D. Wyatt and Daniel E. Hecker, Occupational changes in the 20th century. Monthly Labor Review, March 2006 pp 35-57: Office of Occupational Statistics and Employment Projections, Bureau of Labor Statistics.
  34. ;
  35. MMWR Weekly Report June 1, 2007 / 56(21);524-528; Table 1.
  36. MMWR Weekly Report May 11, 2012 / 61(18);317-322.
  37. Geller AC, Colditz G, Oliveria S, Emmons K, Jorgensen C, Aweh GN, Frazier AL. Use of sunscreen, sunburning rates, and tanning bed use among more than 10,000 US children and adolescents. Pediatrics 2002; 109:1009-14; PMID:12042536; http://
  38. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169:626-32; PMID:19307527;
  39. White MR, Garland FC, Garland CF, Shaw E, Gorham ED. Malignant melanoma in US Navy personnel. Report No. 88-27 Naval Medical Research and Development Command 1988.
  40. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980; 9:227-31; PMID:7440046; http://dx.doi. org/10.1093/ije/9.3.227
  41. Gallagher RP, Elwood JM, Yang CP. Is chronic sunlight exposure important in accounting for increases in melanoma incidence? Int J Cancer 1989; 44:813-5; PMID:2583861;
  42. Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: Randomized trial follow-up. J Clin Oncol 2011; 29:257-63; PMID:21135266;
  43. Neale R, Williams G, Green A. Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial. Arch Dermatol 2002; 138:1319-25; PMID:12374537; http://dx.doi. org/10.1001/archderm.138.10.1319
  44. Dobbinson S, Borland R. Reaction to the 1996/1997 SunSmart Campaign: Results from a Representative Household Survey of Victorians. Melbourne, Australia Anti-Cancer Council of Victoria 1999; SunSmart Evaluation Studies No. 6.
  45. Morris J, McGee R, Bandaranayake M. Sun protection berhaviours and the predictors of sunburn in young children. J Paediatr Child Health 1998; 34:557-62.
  46. fessional/
  47. van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Bio Prev 2006; 15:2546-8; 10.1158/1055-9965.EPI-06-0352
  48. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM. Incidence estimate of non-melanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146:283-7; PMID:20231499;
  49. Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of non-melanoma skin cancer (keratinocyte carcinomas) in the US Population, 2012. JAMA Dermatol 2015; 151:1081-6; PMID:25928283;
  50. Asgari MM, Moffet HH, Ray GT, Quesenberry CP. Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012. JAMA Dermatol 2015; 151:976-81; PMID:26039887; http://dx.
  51. de Vries E, Arnold M, Altsitsiadis E, Trakatelli M, Hinrichs B, Stockfleth E. Coebergh J on behalf of the EPIDERM Group. Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010-2050. Brit J Derm 2012; 167 (Suppl. 2):53-62; PMID:22881588; 10.1111/j.1365-2133.2012.11087.x
  52. Rosso S, Zanetti R, Martinez C, Tormo MJ, Schraub S, Sancho-Garnier H, Franceschi S, Gafa L, Perea E, Navarro C, et al. The multicentre south European study ‘Helios’ II: different sun exposure patterns in the aetiology of basal cell and squamous dell carcinomas of the skin. Br J Cancer 1996; 73:1447-54; PMID:8645596;
  53. English DR, Armstrong BK, Kricker A, Winter MG, Heenan PJ, Randell PL. Case-control study of sun exposure and squamous cell carcinoma of the skin. Int J Cancer 1998; 77:347-53; PMID:9663594; http://dx.doi. org/10.1002/(SICI)1097-0215(19980729)77:3%3c347:: AID-IJC7%3e3.0.CO;2-O
  54. Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, McLean DI, Threlfall WJ. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995; 131:157-63; PMID:7857111; archderm.1995.01690140041006
  55. Gallagher RP, Hill GB, Bajdik CD, Coldman AJ, Fincham S, McLean DI, Threlfall WJ. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 1995; 131:164-9; PMID:7857112;
  56. Schmitt J, Seidler A, Diepgen TL, Bauer A. Occupational ultraviolet light exposure increases the risk of the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis. Br J Dermatol 2011; 164:291-307; PMID:21054335; http://
  57. Bauer A, Diepgen TL, Schmitt J. Is occupational solar ultraviolet irradiation a relevant risk factor for basal cell carcinoma? A systematic review and meta-analysis of the epidemiological literature. Br J Dermatol 2011; 165:612-25; PMID:21605109
  58. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344:975-83; PMID:11274625; http://
  59. Final Recommendation Statement: Skin Cancer Counseling. U.S. Preventive Services Task Force. May 2012.
  60. Lin JS, Eder M, Weinmann S. Behavioral counseling to prevent skin cancer: A systematic review for the U.S. Preventative Services Task Force. Ann Intern Med 2011; 154:190-201; PMID:21282699; 10.7326/0003-4819-154-3-201102010-00009
  61. Holick MF. The UV Advantage, iBooks 2003.
  62. Holick MF. Biologic effects of sunlight, ultraviolet radiation, visible light, infrared, and vitamin D for health. Anticancer 2016; 36:1345-56.
  63. Hossain-nezhad A, Holick MF. Vitamin D for health: A global perspective. Mayo Clinic Proc 2013; 88:720-55;
  64. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Chatper 4. National Academies Press. 2010:142-5.
  65. Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin physiology: A D-Lightful story. J Bone Mineral Res 2007; 22:V28-33;
  66. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96:1911-30; PMID:21646368; 10.1210/jc.2011-0385
  67. Khayznikov M, Hemachrandra Pandit R, Kumar A, Wang P, Glueck CJ. Statin intolerance because of myalgia, myositis, mypathy, or myonecrosis can in most cases be safely resolved by vitamin D supplementation. N Am J \Med Sci 2015; 7:86-91; PMID:25838999;
  68. Rosen CJ. Vitamin D insufficiency. N Eng J Med 2011; 364:248-54;
  69. Holick MF. Cancer, sunlight and vitamin D. J Clin Transl Endocrinol 2014; 1:179-86; 10.1016/j.jcte.2014.10.001
  70. Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: Global perspective. Ann Epidemiol 2009; 19:468-83; PMID:19523595; http://dx.
  71. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 versus 200-2004. Am J Clin Nutr 2008; 88:1519-27; PMID:19064511;
  72. Chowdury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, et al. Vitamin D and risk of cause specific death: systematic review and metaanalysis of observational cohort and randomised intervention studies. BMJ 2014; 348:g1903; PMID:24690623;
  73. Garland CF, Kim JJ, Mohr SB, Gorham ED, Grant WB, Giovannucci EL, Baggerly L, Hofflich H, Ramsdell JW, Zeng K, et al. Meta-Analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Pub Health 2014; 104:e43-50; AJPH.2014.302034
  74. Schottker B, Peasey A, Thorand B, Jansen EHJM, de Groot L, Streppel M, Gardiner J, Ordonez-Mena JM, Perna L, Wilsgaard T, et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 2014; 348:g3656; PMID:24938302;
  75. Lindqvist PG, Epstein E, Landin-Olsson M, Ingvar C, Nielsen K, Stenbeck M, Olsson H. Avoidance of sun exposure is a risk factor for all-cause mortality: results from the melanoma in Southern Sweden cohort. J Intern Med 2014; 276:77-86; PMID:24697969; http://dx.
  76. Lindqvist PG, Epstein E, Nielsen K, Landin-Olsson M, Ingvar C, Olsson H. Avoidance of sun exposure as a risk factor for major causes of death: A competing risk analysis of the melanoma in a southern Sweden cohort. J Int Med 2016; 280:375-87; joim.12496
  77. Afzal S, Brondum-Jacobsen P, Bojesen SE, Nordestgaard BG. Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts. BMJ 2014; 349:G6330; PMID:25406188;
  78. Rebel H, der Spek CD, Salvatori D, van Leeuwen JP, Robanus-Maanday EC, de Gruijl FR. UV exposure inhibits intestinal tumor growth and progression to malignancy in intestine-specific Apc mutant mice kept on low vitamin D diet. Int J Cancer 2014; 136:271-7; PMID:24890436;
  79. Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T, Jansen EH, Slimani N, Byrnes G, Rinaldi S, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ 2010; 340:b5500; PMID:20093284;
  80. Mohr SB, Gorham ED, Kim J, Hofflich H, Garland CF. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer Res 2014; 34:1163-6; PMID:24596354
  81. Engel P, Fagherazzi G, Boutten A, Dupre T, Mesrine S, Boutron-Rualt MC, Clavel-Chapelon F. Serum 25(OH) D vitamin D and risk of breast cancer: A nested case- control study from the French E3N Cohort. Cancer Epidemiol Bio Prev 2010; 19:2341-50; 10.1158/1055-9965.EPI-10-0264
  82. John E, Schwartz G, Dreon D, Koo J. Vitamin D and breast cancer risk: The NHANES I epidemiologic follow-up study, 1971-75 to 1992. Cancer Epidemiol Bio Prev 1999; 8:399-406.
  83. Knight JA, Lesosky M, Barnett H, Raboud JM, Vieth R. Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Bio Prev 2007; 16: 422-9; 9965.EPI-06-0865
  84. van der Rhee H, Coebergh JW, de Vries E. Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies. Eur J Cancer. 2013; 49:1422-36; PMID:23237739;
  85. Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Res 1941; 1:191-5.
  86. Zhao Y, Chen C, Pan W, Gao M, He W, Mao R, Lin T, Huang J. Comparative efficacy of vitamin D status in reducing the risk of bladder cancer: A systematic review and network meta-analysis. Nutrition 2016; 32:515-23; PMID:26822497; http://dx.doi. org/10.1016/j.nut.2015.10.023
  87. Liu D, Fernandez BO, Hamilton A, Lang NN, Gallagher JMC, Newby DE, Feelisch M, Weller RB. UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase. J Invest Dermatol 2014; 134:1839-46; PMID:24445737;
  88. Feelisch M, Kolb-Bachofen V, Liu D, Lundberg JO, Rev- elo LP, Suschek CV, Weller RB. Is sunlight good for our heart? Eur Heart J 2010; 31: 1041-5; PMID:20215123;
  89. Tunstall-Pedoe H, Woodward M, Hughes M, Anderson A, Kennedy G, Balch J, Kuulasmaa K. Prime Mover or fellow treaveller: 25-hydroxy vitamin D’s seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC). Int J Epidemiol 2015; 1602-12; PMID:26095374; 10.1093/ije/dyv092
  90. Vitezova A, Zillikens MC, van Herpt TTW, Sijbrands EJG, Hofman A, Uitterlinden AG, Franco OH, Kiefte- de Jong JC. Vitamin D status and metabolic syndrome in the elderly: the Rotterdam Study. Eur J Endocrin 2015; 172:327-35;
  91. Clemente-Postigo M, Munoz-Garach A, Serrano M, Garrido-Sanchez L, Bernal-Lopez MR, Fernandez-Gar- cia D, Moreno-Santos I, Garriga N, Castellano-Castillo D, Camargo A, et al. Serum 25-hydroxyvitamin D and adipose tissue vitamin D receptor gene expression: relationship with obesity and type 2 diabetes. J Clin Endocrinol Metab 2015; 100:E591-5; PMID:25706239; http://
  92. Geldenhuys S, Hart PH, Endersby R, Jacoby P, Feelisch M, Weller RB, Matthews V, Gorman S. Ultraviolet radiation suppresses obesity and symptoms of metabolic syndrome independently of vitamin D in mice fed a high-fat diet. Diabetes 2014; 63:3759-69; PMID:25342734; http://dx.doi. org/10.2337/db13-1675
  93. Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxy- vitamin D and risk of Type 2 diabetes: A prospective cohort study and metaanalysis. Clin Chem 2013; 59:381-91; PMID:23232064; clinchem.2012.193003
  94. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011; 65:1005-15; PMID:21731035; ejcn.2011.118
  95. Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PHM, Fried L, Kestenbaum GR, Kuller LH, Langa KM, et al. Vitamin D the risk of dementia and Alzheimer disease. Neurology 2014; 83:920-8; PMID:25098535; WNL.0000000000000755
  96. Keeney JTR, Forster S, Sultana R, Brewer LD, Latimer CS, Cai J, Klein JB, Porter NM, Butterfield BA. Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: Implications for low vitamin D-dependent age-related cognitive decline. Free Radic Biol Med 2013; 65:324-34; PMID:23872023; 10.1016/j.freeradbiomed.2013.07.019
  97. Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O. Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis 2013; 37:147-71; PMID:23948884
  98. Balion C, Griffith LE, Strifler L. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 2012; 79:1397-405; PMID:23008220; http://
  99. Slinen Y, Paudel M, Taylor BC, Ishani A, Rossom R, Yaffe K, Blackwell T, Lui L-Y, Hochberg M, Ensrud KE, for the Study of Osteoporotic Fractures Research Group. Association between serum 25(OH)Vitamin D and the risk of cognitive decline in older women. J Gerontol A Biol Sci Med Sci 2012; 67:1092-8; PMID:22454371;
  100. Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly US population. J Gerontol A Biol Sci Med Sci 2011; 66:59-65; PMID:21041201; gerona/glq185
  101. Dickens AP, Lang IA, Langa KM, Kos K, Llewellyn DJ. Vitamin D, cognitive dysfunction and dementia in older adults. CNS Drugs 2011; 24:629-39; 10.2165/11593080-000000000-00000
  102. Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubuni A, Ferrucci L, Melzer D. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010; 170:1135-41; PMID:20625021;
  103. Wang Y, Marling SJ, Beaver EF, Severson KS, Deluca HF. UV light selectively inhibits spinal cord inflammation and demyelination in experimental autoimmune encephalomyelitis. Arch Biochem Biophys 2015; 587:75-82;
  104. Becklund BR, Severson KS, Vang SV, DeLuca HF. UV radiation suppresses experimental encephalomyelitis independent of vitamin D production. Proc Natl Acad Sci USA 2010; 197:6418-23; pnas.1001119107
  105. Knippenberg S, Damoiseaux J, Bol Y, Hupperts R, Taylor BV, Ponsonby A-L, Dwyer T, Simpson T, van der Mei IAF. Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis. Acta Neurol Scand 2014; 129:123-31; PMID:23763464;
  106. Correale J, Farez MF. Modulation of multiple sclerosis by sunlight exposure: role of cis-urocanic acid. J Neuro- immunol 2013; 261:134-40; PMID:23800457; http://dx.
  107. Simpson Jr S, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011; 82:1132-41; PMID:21478203; http://dx.
  108. Ponsonby AL, Lucas RM, van der Mei IAF. UVR, vitamin D and three autoimmune diseases-multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem Photobiol. 2005; 81:1267-75; PMID:15971932; http://dx.
  109. Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psychiatr Scand Suppl 1960; 35:13247; PMID:13681205; 0447.1960.tb08674.x
  110. Baarnhielm M, Hedstrom AK, Kockum I, Sundqvist E, Gustafsson SA, Hillert J, Olsson T, Alfredsson L. Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15. Eur J Neuro 2012; 19:955-62; j.1468-1331.2011.03650.x
  111. Hogancamp WE, Rodriguez M, Weinshenker BG. The epidemiology of multiple sclerosis. Mayo Clin Proc 1997; 72:871-8; PMID:9294536;
  112. Bach J-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Eng J Med 2002; 347:911-20;
  113. Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Leong A, Greenwood CMT, Thanassoulis G, Richards JB. Vitamin D and risk of multiple sclerosis: A Mende- lian randomization study. PLOS Med 2015; 12(8): e1001866; PMID:26305103; journal.pmed.1001866
  114. Jalkanen A, Kauko T, Turpeinen U, Hamalainen E, Airas L. Multiple sclerosis and vitamin D during pregnancy and lactation. Acta Neurol Scand 2015: 131:64-7; PMID:25216350;
  115. Jacobsen R, Frederiksen P, Heitmann BL. Exposure to sunshine early in life prevented development of type 1 diabetes in Danish boys. J Pediatr Endocrinol Metab 2016; 19:417-24.
  116. Sawah SA, Compher CW, Hanlon AL, Lipman TH. 25- Hydroxyvitamin D and glycemic control: a crosssectional study of children and adolescents with type 1 diabetes. Diabetes Res Clin Prac 2016; 115:54-9; http://
  117. Kostoglou-Athanassiou I, Athanassiou P, Lyraki A, Raftakis I, Antoniadis C. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab 2012; 3:181-7; PMID:23323190; 10.1177/2042018812471070
  118. Gisondi P, Rossini M, De Cesare A, Idolazzi L, Farini S, Beltrami G, Peris K, Girolomini G. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol 2012; 166:505-10; PMID:22013980; 10.1111/j.1365-2133.2011.10699.x
  119. Gorman S, Black LJ, Feelisch M, Hart PH, Weller R. Can Skin Exposure to Sunlight Prevent Liver Inflammation? Nutrients 2015; 7:3219-39; PMID:25951129;
  120. Gorman S, Scott NM, Tan DH, Weeden CD, Tuckey RC, Bisley JL, Grimbaldeston MA, Hart PH. Acute erythemal ultraviolet radiation causes systemic immun- suppression in the absence of increased 25-hydroxyvita- min D levels in male mice. PLoS ONE 2012; 7:e46006; PMID:23049920; pone.0046006
  121. Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY, Huang YZ, Honda H, Chan KD, Wang CC, et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 2011; 55:415-25; PMID:21184788; 10.1016/j.jhep.2010.11.028
  122. Feelisch M, Gorman S, Weller RB. Vitamin D status and ill health. Lancet Diab Endocrin 2014; 2:e8; http://dx.
  123. Aleksic S, et al. Abstract 404 Presented at AACE 24th Annual Scientific & Clinical Congress, May 13-17, 2015, Nashville, TN.
  124. Millen AE, Meyers KJ, Liu Z, Engelman CD, Wallace RB, LeBlanc ES, Tinker LF, Lyengar SK, Robinson JG, Sarto GE, et al. Association between vitamin D status and age-related macular degeneration by genetic risk. JAMA Ophthalmol 2015; 133:1171-9; published online August 27, 2015; PMID:26312598; 10.1001/jamaophthalmol.2015.2715
  125. Schroth RJ, Lavelle C, Tate R, Bruce S, Billings RJ, Moffatt MEK. Prenatal vitamin D and dental caries in infants. Pediatrics 2014; 133:e1277-84; PMID:24753535;
  126. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014; 2:76-89; PMID:24622671; http://dx.
  127. Vanlint S. Vitamin D and Obesity. Nutrients 2013; 5:949-56; PMID:23519290;
  128. French AN, Ashby RS, Morgan IG, Rose KA. Time outdoors and the prevention of myopia. Exp Eye Res 2013; 114:58-68; PMID:23644222;
  130. Vitale S, Sperduto RD, Ferris FL III. Increased Prevalence of Myopia in the U.S. between 19711972 and 1999-2004. Arch Ophthalmol 2009; 127:1632-9; PMID:20008719;
  131. Saw S-M, Gazzard G, Shih-Yen EC, Chua W-H. Myopia and associated pathological complications. Ophthal Physiol Opt 2005; 25:381-91; j.1475-1313.2005.00298.x
  132. Chen S-J, Lu P, Zhang W-F, Lu J-H. High myopia as a risk factor in primary open angle glaucoma. Int J Ophthalmol 2012; 5:750-3; PMID:23275912
  133. Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD. Effect of sunlight and season on serotonin turnover in the brain. Lancet 2002; 360:1840-2; PMID:12480364;
  134. Duncan JR, Paterson DS, Hoffman JM, Mokler DJ, Borenstein NS, Belliveau RA, Krous HF, Haas EA, Stanley C, et al. Brainstem Serotonergic Deficiency in Sudden Infant Death Syndrome. JAMA 2010; 303:430-7; PMID:20124538;
  135. Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, Vaugeois JM, Nomikos GG, Greengard P. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006; 311:77-80; PMID:16400147; /science.1117571
  136. Abi-Dargham A, Laruelle M, Aghajanian GK, Charney D, Krystal J. The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiat 1997; 9:1-17;
  137. Cross AJ. Serotonin in Alzheimer-type dementia and other dementing illness. Ann NY Acad Sci 1990; 600:405-17; PMID:1701291; j.1749-6632.1990.tb16897.x
  138. Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia 2007; 27:1295-300; http://dx.
  139. Goldfarb AH, Jamurtas AZ. Beta-endorphin response to exercise. An update. Sports Med 1997; 24:8-16; PMID:9257407;
  140. Fell GL, Robinson KC, Mao J, Woolf CJ, Fisher DE. Skin Beta-Endorphin Mediates Addiction UV Light. Cell 2014; 157:1527-34; PMID:24949966;
  141. Kroll MH, Bi C, Garber CC, Kaufman HW, Liu D, Caston-Balderrama A, Zhang K, Clarke N, Xie M, Reitz RE, et al. Temporal relationship between vitamin D status and parathyroid hormone in the United States. PLoS One 2015; 10(3):e0118108; PMID:25738588; http://dx.

8973 visitors, last modified 29 Apr, 2019,
Printer Friendly Follow this page for updates